agilon health, inc. · NYSE (us_market)
Healthcare · Medical Care Facilities · United States
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-16$25.50 RISE2026-03-31$7.91 PEAK2026-05-29$92.28 133d | -69.0% 74d | Missed | Missed | — | — | +1066.6% 59d | Missed |
DROP2025-10-08$27.25 RISE2026-02-17$8.85 PEAK2026-05-13$72.01 217d | -67.5% 132d | Missed | Missed | — | — | +713.7% 85d | Missed |
DROP2025-07-23$57.25 RISE2025-11-19$12.83 PEAK2026-01-15$25.50 176d | -77.6% 119d | Missed | Missed | — | — | +98.8% 57d | Missed |
DROP2025-04-11$142.00 RISE2025-08-11$21.58 PEAK2025-08-25$34.50 136d | -84.8% 122d | Missed | Missed | — | — | +59.9% 14d | Missed |
DROP2025-04-11$142.00 RISE2025-06-17$52.50 PEAK2025-07-03$60.75 83d | -63.0% 67d | Missed | Missed | — | — | +15.7% 16d | Missed |
DROP2025-04-11$142.00 RISE2025-06-05$52.50 PEAK2025-07-03$60.75 83d | -63.0% 55d | Missed | Missed | — | — | +15.7% 28d | Missed |
DROP2025-01-23$92.25 RISE2025-03-03$74.50 PEAK2025-04-11$142.00 78d | -19.2% 39d | Missed | Missed | — | — | +90.6% 39d | Missed |
DROP2024-08-15$123.00 RISE2024-12-23$46.25 PEAK2025-03-21$113.25 218d | -62.4% 130d | Missed | Missed | — | — | +144.9% 88d | Missed |
DROP2024-07-30$188.00 RISE2024-11-18$39.25 PEAK2025-01-23$92.25 177d | -79.1% 111d | Missed | Missed | — | — | +135.0% 66d | Missed |
DROP2024-06-14$172.50 RISE2024-07-10$141.00 PEAK2024-07-30$188.00 46d | -18.3% 26d | Missed | Missed | — | — | +33.3% 20d | Missed |
DROP2023-12-14$339.25 RISE2024-04-15$111.50 PEAK2024-06-13$172.50 182d | -67.1% 123d | Missed | Missed | — | — | +54.7% 59d | Missed |
DROP2023-10-17$495.00 RISE2024-01-30$142.75 PEAK2024-02-12$186.25 118d | -71.2% 105d | Missed | Missed | — | — | +30.5% 13d | Missed |
DROP2023-08-07$503.50 RISE2023-11-30$265.50 PEAK2023-12-14$339.25 129d | -47.3% 115d | Missed | Missed | — | — | +27.8% 14d | Missed |
DROP2023-06-13$526.75 RISE2023-10-03$428.75 PEAK2023-10-17$495.00 126d | -18.6% 112d | Missed | Missed | — | — | +15.5% 14d | Missed |
DROP2023-04-18$704.50 RISE2023-08-24$418.00 PEAK2023-10-17$495.00 182d | -40.7% 128d | Missed | Missed | — | — | +18.4% 54d | Missed |
1–15 / 24 1 / 2 | |||||||
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is how Agilon Health (AGL) and Humacyte, Inc. (HUMA) have performed compared to their sector so far this year.
Agilon (AGL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Barclays analyst Andrew Mok upgrades Agilon Health (NYSE:AGL) from Underweight to Equal-Weight and announces $81 price target.
Seven small-cap stocks rallied past 100% in May 2026 as first-quarter earnings reset risk appetite below the mega-caps.
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $13 to $95.
Agilon Health Inc. (NYSE:AGL) is one of the best performing NYSE stocks so far in 2026. On April 27, Agilon Health announced the appointment of Tim O’Rourke as Chief Executive Officer and a member of the Board of Directors, effective May 7. He succeeds Ronald A. Williams, who has served as Executive Chairman since August 2025 […]
Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought when above 70. AVNS +127% past 6 months, AGL +212% past month.
Agilon Health’s first quarter saw a marked positive reaction from the market, reflecting a combination of operational progress and strategic focus on profitability. Management credited the quarter’s performance to enhanced data capabilities, disciplined payer contracting, and improved physician engagement. Executive Chairman Ronald Williams emphasized that “operational discipline, the strength of our long-term physician partnerships, and early benefits from the strategic decisions we made last y
Micron's 90% one-month rally has been the loudest story of the AI memory cycle. Ten Russell 2000 stocks just blew past it, with one up 381%.
agilon health (AGL) drew fresh attention after its first quarter report showed revenue of US$1,420.46 million, lower than a year earlier, along with higher net income, stronger earnings per share, and raised 2026 sales guidance. See our latest analysis for agilon health. The first quarter update and raised 2026 sales guidance have arrived alongside very sharp short term share price gains, with a 30 day share price return of 265.62% and year to date share price return of 312.95%. However, the...
TD Cowen analyst Ryan Langston maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $17 to $55.
Here is how Agilon Health (AGL) and Amarin (AMRN) have performed compared to their sector so far this year.
AGL stock sees profit taking after soaring 100%. Agilon Health crushed Q1 estimates with $1.80 EPS and raised its 2026 sales guidance.
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $37.5 to $72.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AGL | +211.97% | +499.22% | +435.73% | +66.27% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +209.00% | +504.94% | +439.18% | +53.58% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-03upcoming | 0.47 | — | — |
| 2026-05-06 | 0.83 | 1.14 | +37.12% |
| 2026-02-25 | -6.80 | -11.50 | -69.10% |
| 2025-11-04 | -4.11 | -6.75 | -64.07% |
| 2025-08-04 | -2.93 | -6.25 | -113.66% |
| 2025-05-06 | -0.29 | 0.75 | +355.58% |
| 2025-02-25 | -5.32 | -6.25 | -17.54% |
| 2024-11-07 | -2.14 | -6.98 | -225.73% |
| 2024-08-06 | -1.46 | -1.81 | -23.72% |
| 2024-05-07 | -0.22 | -0.37 | -68.37% |
| 2024-02-27 | -6.93 | -10.27 | -48.23% |
| 2023-11-02 | -1.55 | -2.00 | -29.10% |
| 2023-08-03 | — | -1.00 | — |
| 2023-05-09 | 1.50 | 0.95 | -36.67% |
| 2023-03-01 | -1.13 | -1.01 | +10.49% |
| 2022-11-03 | -1.27 | -1.75 | -37.79% |